abstract |
The present invention relates to compounds of formula I and formula II, preparations thereof, autoimmune disorders, organ transplant rejection, activated immune system related disorders, and other disorders modulated by lymphopenia or S1P receptors. Provided are their use as pharmaceutically active immunosuppressive agents for therapy. |